SEARCH RESULTS FOR: "Tag: SAGE"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2021(1)
2020(2)
2019(5)
2018(5)
2017(6)
2016(5)
2015(3)
CATEGORIES
Analyst Update(4)
Buzz Stocks(9)
By the Numbers(1)
Earnings Preview(1)
Expectational Analysis(1)
General(1)
Indexes and ETFs(1)
Midday Market Check(2)
Opening View(3)
Quantitative Analysis(2)
Stock Market News(1)
Stocks On the Move(4)
Trade Postmortem(1)
Unusual Trading Activity(2)

6/15/2021 11:07 AM
The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 16.5% to trade at $60.85 at last check, following lackluster Phase 3 test results for the biotechnology company's depression drug, Zuranolon...
12/1/2020 11:57 AM
The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 1.8% at $72.78 at last check, after Raymond James downgraded the stock to "Market Perform" from "Outperform," following its recent $1.5 bill...
3/27/2020 12:45 PM
A long volatility/ straddle strategy might be a good idea for the current roller-coaster market environment we're experiencing. Having a set allocation of your portfolio with these types of trades can...
12/5/2019 11:54 AM
Stocks are generally searching for direction at midday, as investors consider a muddied outlook for U.S.-China trade talks. The Dow Jones Industrial Average (DJI), S&P 500 Index (SPX), and Nasdaq...
3/20/2019 9:37 AM
The shares of SAGE Therapeutics Inc (NASDAQ:SAGE) are up 2% at $159.20, after its postpartum depression (PPD) drug, Zulresso, was approved by the Food and Drug Administration (FDA). Some experts' ne...
 
Special Offers from Schaeffer's Trading Partners